Share Email Print

Proceedings Paper

Targeted delivery of peptide-conjugated biocompatible gold nanoparticles into cancer cell nucleus
Author(s): Wei Qian; Taeyjuana Curry; Yong Che; Raoul Kopelman
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Nucleus remains a significant target for nanoparticles with diagnostic and therapeutic applications because both genetic information of the cell and transcription machinery reside there. Novel therapeutic strategies (for example, gene therapy), enabled by safe and efficient delivery of nanoparticles and drug molecules into the nucleus, are heralded by many as the ultimate treatment for severe and intractable diseases. However, most nanomaterials and macromolecules are incapable of reaching the cell nucleus on their own, because of biological barriers carefully honed by evolution including cellular membrane and nuclear envelope. In this paper, we have demonstrated an approach of fabrication of biocompatible gold nanoparticle (Au NP)-based vehicles which can entering into cancer cell nucleus by modifying Au NPs with both PEG 5000 and two different peptides (RGD and nuclear localization signal (NLS) peptide). The Au NPs used were fabricated via femtosecond laser ablation of Au bulk target in deionized water. The Au NPs produced by this method provide chemical free, virgin surface, which allows us to carry out “Sequential Conjugation” to modify their surface with PEG 5000, RGD, and NLS. “Sequential Conjugation” described in this presentation is very critical for the fabrication of Au NP-based vehicles capable of entering into cancer cell nucleus as it enables the engineering and tuning surface chemistries of Au NPs by independently adjusting amounts of PEG and peptides bound onto surface of Au NPs so as to maximize their nuclear targeting performance and biocompatibility regarding the cell line of interest. Both optical microscopy and transmission electron microscopy (TEM) are used to confirm the in vitro targeted nuclear delivery of peptide-conjugated biocompatible Au NPs by showing their presence in the cancer cell nucleus.

Paper Details

Date Published: 22 February 2013
PDF: 8 pages
Proc. SPIE 8595, Colloidal Nanocrystals for Biomedical Applications VIII, 85951D (22 February 2013); doi: 10.1117/12.2005328
Show Author Affiliations
Wei Qian, IMRA America Inc. (United States)
Taeyjuana Curry, Univ. of Michigan (United States)
Yong Che, IMRA America Inc. (United States)
Raoul Kopelman, Univ. of Michigan (United States)

Published in SPIE Proceedings Vol. 8595:
Colloidal Nanocrystals for Biomedical Applications VIII
Wolfgang J. Parak; Marek Osinski; Kenji Yamamoto, Editor(s)

© SPIE. Terms of Use
Back to Top